Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04765241
Other study ID # HREBA.CC-20-0397
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 27, 2021
Est. completion date September 2026

Study information

Verified date February 2024
Source AHS Cancer Control Alberta
Contact Leanne Dickau
Phone 4034762416
Email leanne.dickau@ahs.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.


Description:

Background: There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis. Aim: Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors. Methods: The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.


Recruitment information / eligibility

Status Recruiting
Enrollment 320
Est. completion date September 2026
Est. primary completion date September 2025
Accepts healthy volunteers No
Gender All
Age group 15 Years to 39 Years
Eligibility Inclusion Criteria: - Lives in Alberta - Diagnosed with invasive malignancy in Alberta - Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences - Have the ability to read, write and speak English - Have access to the Internet on at least a weekly basis - Have a mobile phone with a text messaging plan - Willing to be randomized to either arm. Exclusion Criteria: - Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q) - Currently pregnant or planning to become pregnant within the next 6 months - Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Physical Activity
The intervention includes a physical activity prescription, a Polar activity tracker watch, access to a private AYA cancer survivor community through the Polar Flow community platform, mHealth nudges and surveys via text messaging, and regular phone or email contact from study staff.

Locations

Country Name City State
Canada Holy Cross Centre Calgary Alberta

Sponsors (2)

Lead Sponsor Collaborator
AHS Cancer Control Alberta University of Calgary

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in weekly minutes of moderate-vigorous intensity physical activity Measured by Actigraph Baseline, 6 months, 12 months, 24 months
Secondary Changes in weekly minutes of sedentary time Measured by Actigraph Baseline, 6 months,12 months
Secondary Changes in weekly minutes of sleep Measured by Actigraph Baseline, 6 months,12 months
Secondary Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality Score Global score range is 0 to 23 where higher scores indicate worse sleep quality Baseline, 6 months,12 months
Secondary Changes in weight Measured in kilograms Baseline, 6 months,12 months
Secondary Changes in body mass index (BMI) Measured by combining height (meters) and weight (kilograms) and reported in kg/m2 Baseline, 6 months,12 months
Secondary Changes in waist and hip circumference Measured in centimeters Baseline, 6 months,12 months
Secondary Changes in cardiorespiratory fitness Measured by peak oxygen consumption in relative (ml/kg/min) values using the incremental Balke and Ware treadmill test with direct measures of gas exchange and ventilation Baseline, 6 months,12 months
Secondary Changes in cardiorespiratory fitness Measured by peak oxygen consumption in absolute (L/min) values using the incremental Balke and Ware treadmill test with direct measures of gas exchange and ventilation Baseline, 6 months,12 months
Secondary Changes in grip strength Measured in kilograms using a hand dynamometer Baseline, 6 months,12 months
Secondary Changes in upper body muscular strength Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM Baseline, 6 months,12 months
Secondary Changes in upper body muscular endurance Measured in kilograms using the maximum number of chest press repetitions completed at 50-70% of estimated 1-RM Baseline, 6 months,12 months
Secondary Changes in lower body muscular strength Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM Baseline, 6 months,12 months
Secondary Changes in lower body muscular endurance Measured in kilograms using the maximum number of leg press repetitions completed at 50-70% of estimated 1-RM Baseline, 6 months,12 months
Secondary Changes in frailty Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) Mental Health Component subscale Score range is from 0 to 100 where higher scores indicate better mental health Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) Physical Health Component subscale Score range is from 0 to 100 where higher scores indicate better physical health Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) Physical Functioning subscale Score range is from 0 to 100 where higher scores indicate higher functioning Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) Role-physical subscale Score range is from 0 to 100 where higher scores indicate higher functioning Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) Bodily Pain subscale Score range is from 0 to 100 where higher scores indicate less pain Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) General Health subscale Score range is from 0 to 100 where higher scores indicate better health Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) Vitality subscale Score range is from 0 to 100 where higher scores indicate higher vitality Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) Social Functioning subscale Score range is from 0 to 100 where higher scores indicate higher functioning Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 (SF-36) Role-emotional subscale Score range is from 0 to 100 where higher scores indicate higher functioning Baseline, 6 months,12 months
Secondary Changes in the Short Form 36 Mental Health subscale Score range is from 0 to 100 where higher scores indicate better mental health Baseline, 6 months,12 months
Secondary Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscale Scores range from 0 to 100 where higher scores indicate more distress Baseline, 6 months,12 months
Secondary Changes in the Cancer Distress Scales for AYAs Physical subscale Scores range from 0 to 100 where higher scores indicate more distress Baseline, 6 months,12 months
Secondary Changes in the Cancer Distress Scales for AYAs Emotional subscale Scores range from 0 to 100 where higher scores indicate more distress Baseline, 6 months,12 months
Secondary Changes in the Cancer Distress Scales for AYAs Cognitive subscale Scores range from 0 to 100 where higher scores indicate more distress Baseline, 6 months,12 months
Secondary Changes in the Cancer Distress Scales for AYAs Cancer Worry subscale Scores range from 0 to 100 where higher scores indicate more distress Baseline, 6 months,12 months
Secondary Changes in the Cancer Distress Scales for AYAs Employment subscale Scores range from 0 to 100 where higher scores indicate more distress Baseline, 6 months,12 months
Secondary Changes in the Cancer Distress Scales for AYAs Education subscale Scores range from 0 to 100 where higher scores indicate more distress Baseline, 6 months,12 months
Secondary Changes in the Cancer Distress Scales for AYAs Practical subscale Scores range from 0 to 100 where higher scores indicate more distress Baseline, 6 months,12 months
Secondary Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscale Score range is from 0 to 80. Higher scores indicate poorer quality of life. Baseline, 6 months,12 months
Secondary Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscale Score range is from 0 to 16 where higher scores indicate poorer cognition Baseline, 6 months,12 months
Secondary Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscale Score range is from 0 to 36 where higher scores indicate poorer cognition Baseline, 6 months,12 months
Secondary Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscale Score range is from 0 to 16 where higher scores indicate poorer cognition Baseline, 6 months,12 months
Secondary Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F) Score range is from 0 to 52 where higher scores indicate less fatigue Baseline, 6 months,12 months
Secondary Changes in the Comprehensive Score for Financial Toxicity (COST) Score range is from 0 to 44 where higher scores indicate better financial wellbeing Baseline, 6 months,12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients